STOCK TITAN

West Announces First-Quarter Dividend

West Pharmaceutical Services (NYSE: WST) has declared its first-quarter 2025 dividend.

(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags
dividends

Rhea-AI Summary

West Pharmaceutical Services (NYSE: WST) has declared its first-quarter 2025 dividend. The Board of Directors approved a dividend payment of $0.21 per share, which will be distributed on February 11, 2025. Shareholders who are on record as of February 7, 2025, will be eligible to receive this dividend payment.

Loading...
Loading translation...

Positive

  • Maintains consistent dividend payment, demonstrating financial stability
  • Continues to return value to shareholders through regular dividend distributions

Negative

  • None.
Argus Session date unavailable
-0.52% session move Open Argus
Details

News Market Reaction – WST

The recorded move for WST in the trading session of this news was -0.52%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

EXTON, Pa., Jan. 28, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that the Company's Board of Directors has approved a first-quarter 2025 dividend of $0.21 per share. The dividend will be paid on February 11, 2025, to shareholders of record as of February 7, 2025.

About West  

West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. With over 10,000 team members across 50 sites worldwide, West helps support our customers by delivering approximately 43 billion components and devices each year.

Headquartered in Exton, Pennsylvania, West in its fiscal year 2023 generated $2.95 billion in net sales. West is traded on the New York Stock Exchange (NYSE: WST) and is included on the Standard & Poor's 500 index. For more information, visit www.westpharma.com. 

All trademarks and registered trademarks used in this release are the property of West Pharmaceutical Services, Inc. or its subsidiaries, in the United States and other jurisdictions, unless otherwise noted.

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/west-announces-first-quarter-dividend-302362284.html

SOURCE West Pharmaceutical Services, Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What is West Pharmaceutical Services' Q1 2025 dividend amount?

West Pharmaceutical Services (WST) announced a Q1 2025 dividend of $0.21 per share.

When will WST pay its Q1 2025 dividend?

WST will pay its Q1 2025 dividend on February 11, 2025.

What is the record date for WST's Q1 2025 dividend?

The record date for WST's Q1 2025 dividend is February 7, 2025.

How can shareholders receive WST's Q1 2025 dividend?

Shareholders must be on record as of February 7, 2025, to receive the Q1 2025 dividend payment.

Keep reading